Marie Selch Tvilum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marie Selch Tvilum has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Mogens Johannsen
Department of Forensic Medicine, Aarhus University, Aarhus, Denmark
2 shared publications - Thomas Bjørnskov Poulsen
Department of Chemistry, Aarhus University, Aarhus, Denmark
2 shared publications - Thomas Tørring
Department of Biological and Chemical Engineering, Aarhus University, Aarhus, Denmark
2 shared publications - Ane Lindegaard Appelt
Department of Oncology, Centre for Cancer and Organ Diseases, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Health Technology, Technical University of Denmark, Copenhagen, Denmark
1 shared publication Ate Haraldsen
Aarhus Univ Hosp, Dept Nucl Med, Aarhus, Denmark
1 shared publicationAzza Ahmed Khalil
Aalborg Univ Hosp, Dept Oncol, Aalborg, Denmark
1 shared publication
Latest Publications
- Open Access
Heterologous Reconstitution of 4-Amidopentadienoate Biosynthesis Identifies the PKS Machinery Responsible for Warhead Formation
The 4-amidopentadienoate (APD) motif is a rare and bioactive pharmacophore found in the cyclic lipodepsipeptide natural products BE-43547, rakicidins, microtermolides, and related compounds. Although several biosynthetic gene clusters associated with this family have been identified, the enzymatic origin of the APD warhead has remained unknown. Here, we investigated APD formation using NRPS engineering to install the unusual APD-associated polyketide synthase (PKS) module from the BE-43547 biosynthetic pathway into heterologous nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) assembly lines expressed in Escherichia coli . The engineered hybrids produced the designed lipopeptide containing the APD moiety, demonstrating that the core biosynthetic machinery is sufficient for APD installation and that no trans-acting enzymes are required. Total synthesis of the target compound enabled structural validation by co-elution, MS/MS analysis, and NMR spectroscopy. Production titers of 59 ± 13 μg L −1 were achieved in the heterologous host. Systematic mutagenesis further revealed that the conserved dehydratase His-Asp catalytic dyad is essential for APD formation, whereas an additional highly conserved histidine is dispensable. These findings establish the biosynthetic origin of the APD warhead and provide a foundation for incorporating this privileged pharmacophore into engineered peptide scaffolds.
Open AccessHeterologous Reconstitution of 4-Amidopentadienoate Biosynthesis Identifies the PKS Machinery Responsible for Warhead Formation
The 4-amidopentadienoate (APD) motif is a rare and bioactive pharmacophore found in the cyclic lipodepsipeptide natural products BE-43547, rakicidins, microtermolides, and related compounds. Although several biosynthetic gene clusters associated with this family have been identified, the enzymatic origin of the APD warhead has remained unknown. Here, we investigated APD formation using NRPS engineering to install the unusual APD-associated polyketide synthase (PKS) module from the BE-43547 biosynthetic pathway into heterologous nonribosomal peptide synthetase/polyketide synthase (NRPS/PKS) assembly lines expressed in Escherichia coli . The engineered hybrids produced the designed lipopeptide containing the APD moiety, demonstrating that the core biosynthetic machinery is sufficient for APD installation and that no trans-acting enzymes are required. Total synthesis of the target compound enabled structural validation by co-elution, MS/MS analysis, and NMR spectroscopy. Production titers of 59 ± 13 μg L −1 were achieved in the heterologous host. Systematic mutagenesis further revealed that the conserved dehydratase His-Asp catalytic dyad is essential for APD formation, whereas an additional highly conserved histidine is dispensable. These findings establish the biosynthetic origin of the APD warhead and provide a foundation for incorporating this privileged pharmacophore into engineered peptide scaffolds.
- Open Access
- 20 February 2026
- Published by Microbiology Society in Microbiology
- Vol. 172 (2) , 001662
Hypoxia-induced production of the cyclolipodepsipeptide BE-43547 by Micromonospora sp. RV43
The urgent need for new antibiotics emphasizes the importance of investigating the many biosynthetic gene clusters that remain silent under standard culture conditions and of assigning functions to the many natural products already discovered. Conventional approaches, such as altering the screening medium composition or culture conditions to trigger production, are often labourious and disconnected from the function of the natural products. In this study, we combine antimicrobial assays and the controlled culture conditions available in benchtop bioreactors to demonstrate that BE-43547, a natural product that exists as a mixture of congeners, is selectively active against Gram-positive bacteria growing anaerobically. Furthermore, we show that the producing organism Micromonospora sp. RV43 activates the biosynthesis of BE-43547 when cultured under low-oxygen conditions. These findings illustrate that linking compound function and regulation cues can provide a powerful strategy for discovering antibiotics with a new mode of action.
- 20 February 2026
- Published by Microbiology Society in Microbiology
- Vol. 172 (2) , 001662
Open AccessHypoxia-induced production of the cyclolipodepsipeptide BE-43547 by Micromonospora sp. RV43
The urgent need for new antibiotics emphasizes the importance of investigating the many biosynthetic gene clusters that remain silent under standard culture conditions and of assigning functions to the many natural products already discovered. Conventional approaches, such as altering the screening medium composition or culture conditions to trigger production, are often labourious and disconnected from the function of the natural products. In this study, we combine antimicrobial assays and the controlled culture conditions available in benchtop bioreactors to demonstrate that BE-43547, a natural product that exists as a mixture of congeners, is selectively active against Gram-positive bacteria growing anaerobically. Furthermore, we show that the producing organism Micromonospora sp. RV43 activates the biosynthesis of BE-43547 when cultured under low-oxygen conditions. These findings illustrate that linking compound function and regulation cues can provide a powerful strategy for discovering antibiotics with a new mode of action.
- Open Access
- 23 January 2024
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 45, 100737
Early radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC
- 23 January 2024
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 45, 100737
Open AccessEarly radiologic and metabolic tumour response assessment during combined chemo-radiotherapy for locally advanced NSCLC